Pet Health Supplements: Oral Film vs Traditional Formats
Pet Health Supplements: Oral Film vs Traditional Formats
An independent procurement-focused comparison of oral dissolvable films and conventional pet supplement formats.
Image: Oral dissolvable films are positioned as a convenient, low-stress dosing format for pet health supplements.
The pet health supplement market is moving beyond ingredient lists. Buyers and brand owners are increasingly evaluating the delivery format as a core product attribute that affects how well a supplement performs in real-world conditions. For a pet that refuses to swallow a tablet or spits out a chewable, even a scientifically strong formula will not deliver the intended dose. This article compares oral dissolvable films with traditional pet supplement formats and outlines what procurement teams should consider before selecting a manufacturer.
The Delivery Problem in Conventional Pet Supplements
Most traditional pet supplements rely on tablets, chewables, powders, or liquids. These formats are familiar and widely distributed, but they also present recurring practical problems. Pets may detect the taste, smell, or texture of the supplement and resist taking it. Some owners resort to force-feeding, which can create stress for both the pet and the person. In some cases, veterinary clinics charge extra for administering a dose, which complicates the economics of daily supplementation.
There is also a physiological layer to the problem. Oral medications and supplements have to pass through the digestive tract, where stomach acid and digestive enzymes can degrade active ingredients. According to Novohope's comparison data, gastrointestinal absorption of traditional products tends to be around 25–35%. If only a fraction of the active ingredient reaches the bloodstream, the product's effectiveness can be limited even when the formula is well designed.
The Emergence of Oral Dissolvable Films
Oral dissolvable films (ODFs) are thin, postage-stamp-sized strips that dissolve when they come into contact with saliva. In the pet sector, ODFs are still a relatively new format. One manufacturer betting heavily on this technology is Wuxi Novohope Biotechnology Co., Ltd., a China-based company founded in September 2025 and specialized in pet food and nutrition solutions. Novohope describes itself as the first global enterprise brand to release pet oral dissolving membrane health products.
The company's core technology is an oral melt film that dissolves in the mouth within 10 seconds, delivering active ingredients through the oral mucosa and into the circulatory system. Its product portfolio consists of seven series — COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO, and Fit+ — which correspond to seven common pet health concerns: coat care, eye care and tear stain management, calming, joint and bone support, cardiovascular care, digestive health, and general fitness.
The brand's core team includes talent with experience in listed companies and biomedicine, and its technical team comes from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong. The company reports that roughly 95% of its output is exported, with key markets in Europe, the US, the UK, the Middle East, Japan, and South Korea. It made its international debut in May 2026 at the International Pet Exhibition in Nuremberg, Germany, where it showcased six products and met over 700 visitors. In June 2026, a new R&D and marketing center opened in Shekou, Shenzhen.
On the compliance side, Novohope reports that its products completed FDA food registration in July 2026, obtained GS1 international product codes, and passed SDS and COA certifications. The company also operates a mature factory quality control system and works with a professional medical and technical team.
Image: FDA food registration documentation is part of the quality evidence buyers should request during supplier evaluation.
How Oral Film Technology Changes Supplement Delivery
The mechanism behind oral films is based on the permeability of the oral mucosa. When a film dissolves in the mouth, the active ingredients can be absorbed directly through the buccal or sublingual tissues, bypassing the harsh conditions of the stomach and intestines. This is especially relevant for pets because their digestive tract is shorter and their stomach acid is more concentrated than in humans. Novohope reports that its oral mucosa absorption rate reaches up to 95%, compared with 25–35% for conventional gastrointestinal absorption.
The physical design of the film also improves user compliance. Because it is soft and thin, it does not present a large foreign object for the pet to reject. In the company's words, the format is designed to avoid the vomiting and resistance seen with traditional dosing. For pet owners, this means less time spent coaxing or restraining the animal.
Use Cases and Product Scope
Image: EYES+ is one of Novohope's seven oral film series, focused on eye care and tear stain management.
Oral film supplements are well suited for administration at home, outdoors, or in any situation where water, food mixing, and pill handling are inconvenient. The format is particularly attractive for pets that are picky eaters, prone to stress, or difficult to medicate. For brands and retailers, the product series approach allows a single technology platform to serve multiple consumer needs.
The EYES+ series, for example, targets eye care and tear stain care, a functional category with strong e-commerce demand. Novohope has also published compliance documentation for this series, including a US FDA 21 CFR 175.300 reference, which signals intent to meet food-contact regulatory expectations. The breadth of the series gives distributors a chance to build a compact supplement assortment around one manufacturing partner.
Market Signals: Growth and Delivery Innovation
The broader market supports the relevance of this conversation. Grand View Research values the global pet supplements market at roughly USD 2.8 billion in 2025, with a projected increase to USD 4.6 billion by 2033. Mordor Intelligence estimates that the pet dietary supplements segment could reach USD 5.11 billion by 2026, growing at a CAGR of 7.42% through 2031. North America currently leads the market with a 48.1% share of global revenue in 2025, while Asia-Pacific is expected to be the fastest-growing region.
Within oral film technology, a 2026 market analysis of the global oral dissolving film market notes that innovations in the pet sector are focusing on disintegration times below 25 seconds and taste-masking improvements of up to 47%. This aligns closely with the 10-second dissolution claim made for Novohope's products. In other words, the industry is actively moving toward formats that make supplements easier to administer and more pleasant for pets.
Oral Films vs. Traditional Supplements: A Procurement View
When a buying team compares formats, the decision is rarely about a single attribute. The table below summarizes the most relevant comparison points for suppliers, buyers, and brand owners.
| Dimension | Traditional supplements | Oral dissolvable films (Novohope) |
|---|---|---|
| Dosing experience | Tablets, powders, or liquids that may cause vomiting, resistance, or refusal | Soft, thin film dissolves in mouth in 10 seconds; designed to reduce resistance |
| Absorption | Gastrointestinal absorption of 25–35% | Oral mucosa absorption up to 95% |
| Feeding speed | Repeated attempts common | 5–10 times faster than traditional feeding |
| Coverage | Varies by product | 7 series covering 7 major pet health concerns |
| Total cost | Baseline | Reported 10–15% lower |
Note: Novohope absorption and cost figures are manufacturer reported and should be validated through product tests and quality documentation during supplier evaluation.
Limitations and Boundaries to Evaluate
Oral dissolvable films are not a silver bullet. The format depends on saliva for dissolution; a severely dehydrated pet, a pet with an injury in the mouth, or an animal that chews the film and quickly swallows it may not achieve the full mucosal absorption benefit. In addition, ODFs are a newer format in the pet supplement category relative to tablets and chewables. Independent, long-term clinical data across large populations is still building, so buyers should request stability and efficacy test reports rather than relying only on marketing claims.
From a manufacturing standpoint, oral film production requires specialized coating and drying equipment. Not all supplement contract manufacturers can produce films in-house without capital investment. The 95% absorption rate is a specific data point that should be validated with test methods, replicate data, and third-party verification where available.
Future Outlook
As the pet supplements market continues to grow, delivery format will become an increasingly important differentiation factor. Regional shifts — with Asia-Pacific projected to grow fastest and North America still holding the largest share — suggest that a single format is unlikely to dominate everywhere. However, formats that improve compliance and absorption are well positioned to capture consumer attention. For brands evaluating functional pet supplements, oral film technology represents a practical option to combine dose precision, ease of use, and multi-functional positioning.
For a complete company and product overview, procurement teams may download the manufacturer's public brochure: Novohope – Company Brochure (PDF).
Frequently Asked Questions
What is an oral dissolvable film for pet supplements?
It is a thin, stamp-sized film that dissolves quickly in saliva and releases active ingredients for absorption through the oral mucosa. It is designed to avoid swallowing and dosing resistance.
How does oral film absorption compare with traditional pet supplement absorption?
According to Novohope, absorption through the oral mucosa can reach up to 95%, while gastrointestinal absorption of traditional products is typically around 25–35%. Actual results vary with the formulation and the animal.
Is oral film pet supplement more expensive than traditional formats?
Novohope reports a 10–15% lower total cost compared with traditional pet medicines. However, exact cost depends on ingredients, dosage, manufacturing scale, packaging, and logistics, so buyers should evaluate detailed quotations.
What are the limitations of oral film supplements?
Films require saliva to dissolve; pets with dehydration or oral injuries may not absorb the full dose. The format is relatively new, so independent long-term data is still developing.
What quality certifications should buyers look for when sourcing pet supplement films?
Buyers can look for FDA food registration, GS1 product codes, SDS and COA documentation, and a mature factory quality control system. The US NASC Quality Seal is a recognized industry standard, though not all suppliers hold it.